The search for a curative cell therapy in Parkinson's disease

Journal of the Neurological Sciences

Volumn 265, Issue 1-2, 2008, Pages 32-42

  Laguna Goya, R ^a   Tyers, P ^a   Barker, R A ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cell replacement; Dopamine; Fetal ventral mesencephalon; Neural precursor cell; Parkinson's disease; Stem cell; Transplantation

Indexed keywords

DOPAMINE;

ADRENAL MEDULLA; ALLOGRAFT; ARTICLE; AUTOGRAFT; CAROTID BODY; CELL THERAPY; DOPAMINE RELEASE; EMBRYONIC STEM CELL; EXPERIMENTAL STUDY; GANGLION; HUMAN; MESENCEPHALON; MESENCHYMAL STEM CELL; NERVE CELL; NERVE GRAFT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STEM CELL; XENOGRAFT;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; HUMANS; NEURONS; PARKINSON DISEASE; STEM CELLS; TISSUE THERAPY;

EID: 38049098051     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.09.006     Document Type: Article

References (114)

1. Klein D., et al. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy. Gene Ther 13 24 (2006) 1686-1695
2. Muller I., et al. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. Exp Hematol 34 10 (2006) 1413-1419
3. Villadiego J., et al. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J Neurosci 25 16 (2005) 4091-4098
4. Martin D., et al. Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury. J Neurosci Res 45 5 (1996) 588-597
5. Ehtesham M., et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62 24 (2002) 7170-7174
6. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318 14 (1988) 876-880
7. Morrish P.K., Sawle G.V., and Brooks D.J. Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. Brain 119 Pt 6 (1996) 2097-2103
8. Bernheimer H., et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20 4 (1973) 415-455
9. Brooks D.J., et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 113 Pt 5 (1990) 1539-1552
10. Cotzias G.C., Van Woert M.H., and Schiffer L.M. Aromatic amino acids and modification of parkinsonism. N Engl J Med 276 7 (1967) 374-379
11. Marsden C.D., and Parkes J.D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1 7954 (1976) 292-296
12. Piccini P., et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2 12 (1999) 1137-1140
13. McGregor K.H., Gil J., and Lahiri S. A morphometric study of the carotid body in chronically hypoxic rats. J Appl Physiol 57 5 (1984) 1430-1438
14. Espejo E.F., et al. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 20 2 (1998) 197-206
15. Toledo-Aral J.J., et al. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci 23 1 (2003) 141-148
16. Luquin M.R., et al. Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron 22 4 (1999) 743-750
17. Arjona V., et al. Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery 53 2 (2003) 321-328 discussion 328-30
18. Fahn S., E.R., and Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: M.C. S., Fahn, Goldstein M., and Calne D. (Eds). Recent developments in Parkinson's Disease (1987), Macmillan, New York
19. Madrazo I., et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 316 14 (1987) 831-834
20. Ahlskog J.E., et al. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies. Mayo Clin Proc 65 3 (1990) 305-328
21. Goetz C.G., et al. United Parkinson Foundation neurotransplantation registry on adrenal medullary transplants: presurgical, and 1- and 2-year follow-up. Neurology 41 11 (1991) 1719-1722
22. Olson L., et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch Neurol 48 4 (1991) 373-381
23. Date I., et al. Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease. Neurosci Res 20 3 (1994) 213-221
24. Howel L.L., et al. Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation. Cell Transplant 9 5 (2000) 609-622
25. Date I., Asari S., and Ohmoto T. Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report. Neurosurgery 37 3 (1995) 515-518 discussion 518-9
26. Date I., et al. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report. J Neurosurg 84 4 (1996) 685-689
27. Lopez-Lozano J.J., et al. Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. Transpl Int 9 Suppl 1 (1996) S485-S491
28. Watts R.L., et al. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study. Exp Neurol 147 2 (1997) 510-517
29. Lopez-Lozano J.J., et al. Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. Clinica Puerta de Hierro Neural Transplantation Group. J Neurosurg 90 5 (1999) 875-882
30. Nakao N., et al. Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease. J Neurosurg 95 2 (2001) 275-284
31. Nakao N., et al. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. Exp Neurol 188 1 (2004) 65-73
32. Horvath M., et al. Autotransplantation of superior cervical ganglion to the caudate nucleus in three patients with Parkinson's disease (preliminary report). Neurosurg Rev 13 2 (1990) 119-122
33. Itakura T., et al. Autologous transplantation of the cervical sympathetic ganglion into the parkinsonian brain: case report. Neurosurgery 35 1 (1994) 155-157 discussion 157-8
34. Itakura T., et al. Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases. Stereotact Funct Neurosurg 69 1-4 Pt 2 (1997) 112-115
35. Perlow M.J., et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204 4393 (1979) 643-647
36. Bjorklund A., and Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177 3 (1979) 555-560
37. Bjorklund A., et al. Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res 199 2 (1980) 307-333
38. Dunnett S.B., et al. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions. Brain Res 229 2 (1981) 457-470
39. Bjorklund A., Schmidt R.H., and Stenevi U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res 212 1 (1980) 39-45
40. Dunnett S.B., et al. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol Scand Suppl 522 (1983) 29-37
41. Wictorin K., et al. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J Comp Neurol 323 4 (1992) 475-494
42. Lindvall O., et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247 4942 (1990) 574-577
43. Lindvall O., et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35 2 (1994) 172-180
44. Freed C.R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344 10 (2001) 710-719
45. Hagell P., et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 5 7 (2002) 627-628
46. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23 7 (2005) 862-871
47. Ma Y., et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 52 5 (2002) 628-634
48. Barker R.A. Porcine neural xenografts: what are the issues?. Novartis Found Symp 231 (2000) 184-196 discussion 196-201, 302-6
49. Phelps C.J., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299 5605 (2003) 411-414
50. Harrower T.P., et al. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue. Xenotransplantation 11 1 (2004) 60-71
51. Patience C., Takeuchi Y., and Weiss R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 3 3 (1997) 282-286
52. Galpern W.R., et al. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Exp Neurol 140 1 (1996) 1-13
53. Barker R.A., et al. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease. J Neurosci 20 9 (2000) 3415-3424
54. Larsson L.C., et al. Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection. Exp Neurol 172 1 (2001) 100-114
55. Fink J.S., et al. Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant 9 2 (2000) 273-278
56. Deacon T., et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 3 3 (1997) 350-353
57. Studer L., Tabar V., and McKay R.D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1 4 (1998) 290-295
58. Studer L., et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20 19 (2000) 7377-7383
59. Sawamoto K., et al. Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene. J Neurosci 21 11 (2001) 3895-3903
60. Storch A., et al. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 170 2 (2001) 317-325
61. Sanchez-Pernaute R., et al. In vitro generation and transplantation of precursor-derived human dopamine neurons. J Neurosci Res 65 4 (2001) 284-288
62. Jain M., et al. GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells in vitro. Exp Neurol 182 1 (2003) 113-123
63. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 5819 (1981) 154-156
64. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78 12 (1981) 7634-7638
65. Li M., et al. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 8 17 (1998) 971-974
66. Ying Q.L., et al. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 21 2 (2003) 183-186
67. Conti L., et al. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol 3 9 (2005) e283
68. Kawasaki H., et al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28 1 (2000) 31-40
69. Takagi Y., et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115 1 (2005) 102-109
70. Lee S.H., et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18 6 (2000) 675-679
71. Kim J.H., et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418 6893 (2002) 50-56
72. Reubinoff B.E., et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 19 12 (2001) 1134-1140
73. Zhang S.C., et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19 12 (2001) 1129-1133
74. Bjorklund L.M., et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 99 4 (2002) 2344-2349
75. Singh Roy N., et al. Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells. Exp Neurol 196 2 (2005) 224-234
76. Jungling K., et al. Purification of embryonic stem cell-derived neurons by immunoisolation. Faseb J 17 14 (2003) 2100-2102
77. Perrier A.L., et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 101 34 (2004) 12543-12548
78. Zeng X., et al. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22 6 (2004) 925-940
79. Roy N.S., et al. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12 11 (2006) 1259-1268
80. Altman J., and Das G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124 3 (1965) 319-335
81. Reynolds B.A., and Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255 5052 (1992) 1707-1710
82. Palmer T.D., Ray J., and Gage F.H. FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol Cell Neurosci 6 5 (1995) 474-486
83. Palmer T.D., et al. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci 19 19 (1999) 8487-8497
84. Tropepe V., et al. Retinal stem cells in the adult mammalian eye. Science 287 5460 (2000) 2032-2036
85. Markakis E.A., et al. Novel neuronal phenotypes from neural progenitor cells. J Neurosci 24 12 (2004) 2886-2897
86. Weiss S., et al. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 16 23 (1996) 7599-7609
87. Lie D.C., et al. The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 22 15 (2002) 6639-6649
88. Hermann A., et al. Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. Stem Cells 24 4 (2006) 949-964
89. Lois C., and Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 90 5 (1993) 2074-2077
90. Kaplan M.S., McNelly N.A., and Hinds J.W. Population dynamics of adult-formed granule neurons of the rat olfactory bulb. J Comp Neurol 239 1 (1985) 117-125
91. Kuhn H.G., Dickinson-Anson H., and Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16 6 (1996) 2027-2033
92. Armstrong R.J., and Barker R.A. Neurodegeneration: a failure of neuroregeneration?. Lancet 358 9288 (2001) 1174-1176
93. Zhao M., et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 100 13 (2003) 7925-7930
94. Shan X., et al. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice. Stem Cells 24 5 (2006) 1280-1287
95. Mao L., et al. Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration. Brain Res Dev Brain Res 131 1-2 (2001) 57-65
96. Steiner B., et al. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease. Exp Neurol 199 2 (2006) 291-300
97. Palfi S., et al. Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 22 12 (2002) 4942-4954
98. Chen Y., et al. Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor. Exp Neurol 196 1 (2005) 87-95
99. Mohapel P., et al. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience 132 3 (2005) 767-776
100. Fallon J., et al. In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci U S A 97 26 (2000) 14686-14691
101. Cooper O., and Isacson O. Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. J Neurosci 24 41 (2004) 8924-8931
102. Custer S.K., et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 9 10 (2006) 1302-1311
103. Shin J.Y., et al. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171 6 (2005) 1001-1012
104. Sapp E., et al. Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60 2 (2001) 161-172
105. Hoglinger G.U., et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 7 7 (2004) 726-735
106. Freundlieb N., et al. Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J Neurosci 26 8 (2006) 2321-2325
107. Van Kampen J.M., Hagg T., and Robertson H.A. Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D receptor stimulation. Eur J Neurosci 19 9 (2004) 2377-2387
108. Van Kampen J.M., and Robertson H.A. A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra. Neuroscience 136 2 (2005) 381-386
109. Bianco P., et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 3 (2001) 180-192
110. Jiang Y., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 6893 (2002) 41-49
111. Dezawa M., et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113 12 (2004) 1701-1710
112. Kim S., et al. Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res 1123 1 (2006) 27-33
113. Wagers A.J., et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297 5590 (2002) 2256-2259
114. Alvarez-Dolado M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 6961 (2003) 968-973